These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33315937)

  • 1. The CH1α domain of mucosal gp41 IgA contributes to antibody specificity and antiviral functions in HIV-1 highly exposed Sero-Negative individuals.
    Khamassi M; Xu L; Rey J; Duchemin M; Bouceba T; Tuffery P; Tudor D; Bomsel M
    PLoS Pathog; 2020 Dec; 16(12):e1009103. PubMed ID: 33315937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis.
    Tudor D; Derrien M; Diomede L; Drillet AS; Houimel M; Moog C; Reynes JM; Lopalco L; Bomsel M
    Mucosal Immunol; 2009 Sep; 2(5):412-26. PubMed ID: 19587640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
    Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
    Front Immunol; 2018; 9():244. PubMed ID: 29651286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody.
    Tudor D; Yu H; Maupetit J; Drillet AS; Bouceba T; Schwartz-Cornil I; Lopalco L; Tuffery P; Bomsel M
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12680-5. PubMed ID: 22723360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection.
    Diomede L; Nyoka S; Pastori C; Scotti L; Zambon A; Sherman G; Gray CM; Sarzotti-Kelsoe M; Lopalco L
    J Virol; 2012 Apr; 86(8):4129-38. PubMed ID: 22301151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of HIV-1 gp41-directed neutralizing and non-neutralizing fragment antibody binding domain (Fab) and single chain variable fragment (ScFv) antibodies to the ectodomain of gp41 in the pre-hairpin and six-helix bundle conformations.
    Louis JM; Aniana A; Lohith K; Sayer JM; Roche J; Bewley CA; Clore GM
    PLoS One; 2014; 9(8):e104683. PubMed ID: 25105806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1.
    Tay MZ; Kunz EL; Deal A; Zhang L; Seaton KE; Rountree W; Eudailey JA; Heptinstall J; McRaven MD; Matias E; McGuire E; Yates NL; Perez LG; Montefiori DC; Overman RG; Hope TJ; Shen X; Kalilani L; Fouda GG; Tomaras GD; Permar SR
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41.
    Clerici M; Barassi C; Devito C; Pastori C; Piconi S; Trabattoni D; Longhi R; Hinkula J; Broliden K; Lopalco L
    AIDS; 2002 Sep; 16(13):1731-41. PubMed ID: 12218383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41.
    Duchemin M; Tudor D; Cottignies-Calamarte A; Bomsel M
    Front Immunol; 2020; 11():1141. PubMed ID: 32582208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket.
    Pastori C; Barassi C; Piconi S; Longhi R; Villa ML; Siccardi AG; Clerici M; Lopalco L
    J Biol Regul Homeost Agents; 2000; 14(1):15-21. PubMed ID: 10763886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity.
    Sojar H; Baron S; Sullivan JT; Garrett M; van Haaren MM; Hoffman J; Overbaugh J; Doranz BJ; Hicar MD
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of IgA-binding sites on human immunodeficiency virus type-1 envelope glycoproteins, Gp120 and Gp41.
    Matsuda S; Noda M
    Microbiol Immunol; 2000; 44(11):923-9. PubMed ID: 11145273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1.
    Cleveland SM; Jones TD; Dimmock NJ
    J Gen Virol; 2000 May; 81(Pt 5):1251-60. PubMed ID: 10769067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based array.
    Gallerano D; Ndlovu P; Makupe I; Focke-Tejkl M; Fauland K; Wollmann E; Puchhammer-Stöckl E; Keller W; Sibanda E; Valenta R
    PLoS One; 2015; 10(2):e0117204. PubMed ID: 25658330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers.
    Broliden K; Hinkula J; Devito C; Kiama P; Kimani J; Trabbatoni D; Bwayo JJ; Clerici M; Plummer F; Kaul R
    Immunol Lett; 2001 Nov; 79(1-2):29-36. PubMed ID: 11595287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.
    Devito C; Hinkula J; Kaul R; Kimani J; Kiama P; Lopalco L; Barass C; Piconi S; Trabattoni D; Bwayo JJ; Plummer F; Clerici M; Broliden K
    J Acquir Immune Defic Syndr; 2002 Aug; 30(4):413-20. PubMed ID: 12138348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative mucosal immunogenicity of HIV gp41 membrane-proximal external region (MPER) containing single and multiple repeats of ELDKWA sequence with defensin peptides.
    Mohan T; Verma P; Rao DN
    Immunobiology; 2014 Apr; 219(4):292-301. PubMed ID: 24290973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.
    Leroux-Roels G; Maes C; Clement F; van Engelenburg F; van den Dobbelsteen M; Adler M; Amacker M; Lopalco L; Bomsel M; Chalifour A; Fleury S
    PLoS One; 2013; 8(2):e55438. PubMed ID: 23437055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A predefined epitope-specific monoclonal antibody recognizes ELDEWA-epitope just presenting on gp41 of HIV-1 O clade.
    Huang J; Dong X; Liu Z; Qin L; Chen YH
    Immunol Lett; 2002 Dec; 84(3):205-9. PubMed ID: 12413738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.